The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk of neutropenia-related hospitalization (NRH) related to duration of short-acting granulocyte colony stimulating factor (sG-CSF) for primary prophylaxis.
 
Shuling Li
Research Funding - Amgen
 
Jiannong Liu
Consulting or Advisory Role - FibroGen
 
Tingting Gong
No Relationships to Disclose
 
Haifeng Guo
No Relationships to Disclose
 
Prasad L. Gawade
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Michael Anthony Kelsh
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Brian D. Bradbury
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen
 
Rajesh Belani
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Gary H. Lyman
Stock and Other Ownership Interests - Generex Biotechnology
Consulting or Advisory Role - Agendia; Amgen; Celldex (I); G1 Therapeutics; Genomic Health; Halozyme; Helsinn Therapeutics; Janssen (I); Mylan; Partners Healthcare; Pfizer; Samsung Bioepis; Spectrum Pharmaceuticals
Research Funding - Hexal